Latest osteosarcoma Stories
Dr. Tsz-Kwong Man, a researcher with the Texas Children's Cancer Center at Baylor College of Medicine, has a received a grant from the Liddy Shriver Sarcoma Initiative to study the function of a protein that may promote the spread of a common form of children's bone cancer called osteosarcoma.
A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens.
SAN MARINO, Calif., Oct. 12 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
A team of Israeli researchers say they have developed a new drug carrier to deliver compounds straight to a tumor to starve it of blood. Dr.
New TAU drug cuts off blood supplies to starve cancer tumors.
ROCKLEIGH, N.J., Sept.
A new analysis suggests patients and physicians should rethink the pros and cons of limb-sparing surgery versus amputation for bone and soft tissue sarcomas of the lower limb.
INDIANAPOLIS, July 23 /PRNewswire-FirstCall/ -- Today, Eli Lilly and Company (NYSE: LLY) announced that the U.S.
SAN MARINO, Calif., June 22 /PRNewswire/ -- Epeius Biotechnologies (www.epeiusbiotech.com) stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer.
A grant from the Liddy Shriver Sarcoma Initiative will allow Dr. Pulivarthi Rao, associate professor of pediatrics at Baylor College of Medicine, and his team of researchers to explore the role of the gene CDC5L in the development of osteosarcoma, the most common bone cancer in children.